바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기



Physician Directory

HOME > Hospitals > Severance Hospital > Departments > Gastroenterology > Physician Directory

Information of doctor

Go list

Heeseung Lee
doctor's information
Name Heeseung Lee
Department
Major
Homepage
Blog

Research

  • Trends in receiving chemotherapy for advanced cancer patients at the end of life.
  • BMC Palliat Care. 2015 Mar 13;14:4.
  • Endoscopic hemostasis using a gauze-ball compression method.
  • Endoscopy. 2014;46
  • Spontaneous Neoplastic Remission of Hepatocellular Carcinoma
  • Korean J Gastroenterol. 2015 May;65(5):312-315
  • Case Reports : Gastroenterology ; Photodynamic Therapy Followed by Left Hepatectomy Used to Treat an Intraductal Papillary Mucinous Neoplasm of the Bile Duct
  • Korean Journal of Medicine, 2015
  • Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer
    CHEMOTHERAPY 61/3 :152-158,2016
  • Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existingdiabetes existingdiabetes mellitus type 2
    DIGESTIVE AND LIVER DISEASE 48/4 :435-440,2016
  • Statin Use and Its Impact on Survival in Pancreatic Cancer Patients Cancer Patients
    MEDICINE 95/19 :e3607-,2016
  • Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25- and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses
    PLOS ONE 11/5 :e0154401-,2016
  • Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51/5 :618-624,2016
  • Systemic Chemotherapy in Advanced Pancreatic Cancer
    GUT AND LIVER 10/3 :340-347,2016
  • Past, Present, and Future of Gastrointestinal Stents: New Endoscopic Ultrasonography- Guided Metal Stents and Future Developments
    Clinical Endoscopy 49/2 :131-138,2016
  • Concomiant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
    YONSEI MEDICAL JOURNAL 57/5 :1,124-1,130,2016
  • A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreatic cancer in South Korea.
    MEDICINE 96/1 :e5702-,2017
  • A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance
    SCIENTIFIC REPORTS 7/41615 :1-9,2017
  • The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer.
    JOURNAL OF MOLECULAR RECOGNITION 30/4 :e2591-,2017
  • Clinical characteristics of second primary pancreatic cancer
    PLOS ONE 12/6 :e0179784-,2017
  • Benefit of neoadjuvant concurrent chemoradiotherapy locally advanced perihilar cholangiocarcinoma
    WORLD JOURNAL OF GASTROENTEROLOGY 23/18 :3,301-3,308,2017
  • The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL 69/3 :512-519,2017
  • Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer
    CHEMOTHERAPY 62/6 :361-366,2017
  • Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer “in a Korean” population: A single-center cohort study
    SEMINARS IN ONCOLOGY 44/ :420-427,2017
  • Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis
    PLOS ONE 13/2 :e0190835-,2018
  • Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer
    SCIENTIFIC REPORTS 8/1 :3,383-3,389,2018
  • Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer.
    GASTROINTESTINAL ENDOSCOPY 87/3 :688-694,2018
  • Revision of bilateral self-expandable metallic stents placed using the stent-in-stent technique for malignant hilar biliary obstruction.
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL 17/5 :437-442,2018
  • Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
    World Journal of Gastrointestinal Oncology 10/11 :421-430,2018
  • Clinical Outcomes of Bilateral Stent-in-Stent Placement Using Self-Expandable Metallic Stent for High-Grade Malignant Hilar Biliary Obstruction
    YONSEI MEDICAL JOURNAL 59/7 :827-833,2018
  • Novel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient Outcome
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20/3 :-,2019
  • KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL 18/1 :62-66,2019
  • Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs
    BMC MEDICAL GENOMICS 12/1 :62-,2019
  • Bleeding Complications and Clinical Safety of Endoscopic Retrograde Cholangiopancreatography in Patients with Liver Cirrhosis
    YONSEI MEDICAL JOURNAL 60/5 :440-445,2019
  • Establishment of pancreatic cancer cell lines with endoscopic ultrasound?guided biopsy via conditionally reprogrammed cell culture
    CANCER MEDICINE 8/7 :3339-3348,2019
  • A novel lumen-apposing metal stent with an anti-reflux valve for endoscopic ultrasound-guided drainage of pseudocysts and walled-off necrosis: A pilot study
    PLOS ONE 14/9 :e0221812-,2019
  • Skeletal Muscle Mass Predicts Poor Prognosis in Patients with Advanced Pancreatic Cancer Undergoing Second-Line FOLFIRINOX Chemotherapy
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL 71/ 7 :1100-1107,2019

콘텐츠 처음으로 이동